ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Oncology Pharma Inc (CE)

Oncology Pharma Inc (CE) (ONPH)

0,0001
0,00
( 0,00% )
Mis à jour : 01:00:00

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,0001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
245
0,0001 Fourchette du Jour 0,0001
0,000001 Plage de 52 semaines 0,1789
Clôture Veille
0,0001
Ouverture
0,0001
Dernière Transaction
200
@
0.0001
Dernière heure de transaction
16:03:17
Volume moyen (3 m)
10 518
Volume financier
US$ 0
VWAP
0,0001

ONPH Dernières nouvelles

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue  Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System San Francisco, CA -- July 12...

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System   San Francisco, CA -- June 29, 2022...

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development...

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development      San Francisco, CA -- May 9, 2022...

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer San Francisco, CA -- April 13, 2022 -- InvestorsHub NewsWire -- Oncology Pharma...

Oncology Pharma Reports on Progress with Ribera Solutions

SAN FRANCISCO, CA -- March 2, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to announce progress with its investment...

Oncology Pharma Releases Further Feasibility Studies, Data and Capacities

SAN FRANCISCO, CA -- February 23, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc. ("The Company") looks toward releasing further results of the...

Oncology Pharma Expands on Feasibility Studies and Data

SAN FRANCISCO, CA -- February 17, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") wants to expand on a...

Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine

San Francisco, CA -- February 14, 2022 -- InvestorsHub NewsWire -- Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen BioPharma, Inc. (OTC PINK:RGBP) and (OTC...

Oncology Pharma Gives Update on Technology, Formulation and Data Creation

SAN FRANCISCO, CA – February 8, 2022 – InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to announce that...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.00010.0010.0001338720.0001122CS
4-0.0001-500.00020.0010.0001199250.00011231CS
129.9E-599001.0E-60.031.0E-6105188.185E-5CS
269.9E-599001.0E-60.125051.0E-696690.00028242CS
52-0.0002-66.66666666670.00030.17891.0E-669110.00024184CS
156-4.0499-99.99753086424.057.231.0E-6528651.73794992CS
260-0.01855-99.46380697050.01865501.0E-61354306.37595094CS

ONPH - Frequently Asked Questions (FAQ)

What is the current Oncology Pharma (CE) share price?
The current share price of Oncology Pharma (CE) is US$ 0,0001
What is the 1 year trading range for Oncology Pharma (CE) share price?
Oncology Pharma (CE) has traded in the range of US$ 0,000001 to US$ 0,1789 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,0019
(189 900,00%)
477
FGHFFForte Group Holdings Inc (PK)
US$ 0,3901
(29 907,69%)
235
SMMESmartMetric Inc (PK)
US$ 0,0001
(9 900,00%)
1,7M
ATYGAtlas Technology Group Inc (PK)
US$ 0,0001
(9 900,00%)
310k
IVSTInnovest Global Inc (CE)
US$ 0,0001
(9 900,00%)
189,48k
SPOISPO Networks Inc (CE)
US$ 0,000001
(-99,95%)
150
EPWCFEmpower Clinics Inc (CE)
US$ 0,000001
(-99,01%)
1 000
ALGWFAlliance Growers Corporation (CE)
US$ 0,000001
(-99,00%)
500
GBHLGlobal Entertainment Holdings Inc (CE)
US$ 0,000001
(-99,00%)
455,55k
HQGEHQ Global Education Inc (CE)
US$ 0,000001
(-99,00%)
850k
TWOHTwo Hands Corporation (PK)
US$ 0,0012
(50,00%)
390,58M
GCANGreater Cannabis Company Inc (PK)
US$ 0,0009
(125,00%)
108,38M
SPRVSupurva Healthcare Group Inc (PK)
US$ 0,00015
(-25,00%)
59,23M
GRLTGrillit Inc (PK)
US$ 0,0009
(0,00%)
53,54M
ENDVEndonovo Therapeutics Inc (PK)
US$ 0,0005
(25,00%)
52,9M
Aucune Discussion Trouvée
Ajouter une Discussion